Compare GCTS & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GCTS | ELMD |
|---|---|---|
| Founded | 1998 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.8M | 204.1M |
| IPO Year | 2021 | 2010 |
| Metric | GCTS | ELMD |
|---|---|---|
| Price | $1.11 | $23.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $3.13 | ★ $48.50 |
| AVG Volume (30 Days) | ★ 1.7M | 37.4K |
| Earning Date | 11-12-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.94 |
| EPS | N/A | ★ 0.32 |
| Revenue | $2,866,000.00 | ★ $54,716,000.00 |
| Revenue This Year | $76.29 | $11.55 |
| Revenue Next Year | $648.00 | $10.94 |
| P/E Ratio | ★ N/A | $74.64 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $0.96 | $22.67 |
| 52 Week High | $3.93 | $47.40 |
| Indicator | GCTS | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 27.98 |
| Support Level | $1.00 | $23.06 |
| Resistance Level | $1.43 | $24.99 |
| Average True Range (ATR) | 0.15 | 1.30 |
| MACD | 0.01 | -0.32 |
| Stochastic Oscillator | 23.83 | 10.09 |
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness. Geographically, operates in South Korea and the United States, with maximum revenue from the USA.
Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.